A Novel TTC19 Mutation in a Patient With Neurological, Psychological, and Gastrointestinal Impairment by Habibzadeh, P. et al.
14 December 2021
AperTO - Archivio Istituzionale Open Access dell'Università di Torino
Original Citation:





(Article begins on next page)
Anyone can freely access the full text of works made available as "Open Access". Works made available under a
Creative Commons license can be used according to the terms and conditions of said license. Use of all other works
requires consent of the right holder (author or publisher) if not exempted from copyright protection by the applicable law.
Availability:
This is the author's manuscript
This version is available http://hdl.handle.net/2318/1800489 since 2021-09-09T13:34:38Z
CASE REPORT
published: 04 September 2019
doi: 10.3389/fneur.2019.00944
Frontiers in Neurology | www.frontiersin.org 1 September 2019 | Volume 10 | Article 944
Edited by:
Jie Shen,





Fondazione Stella Maris (IRCCS), Italy
Georgia Xiromerisiou,





This article was submitted to
Neurogenetics,
a section of the journal
Frontiers in Neurology
Received: 05 April 2019
Accepted: 15 August 2019
Published: 04 September 2019
Citation:
Habibzadeh P, Inaloo S, Silawi M,
Dastsooz H, Farazi Fard MA,
Sadeghipour F, Faghihi Z, Rezaeian M,
Yavarian M, Böhm J and Faghihi MA
(2019) A Novel TTC19 Mutation in a
Patient With Neurological,
Psychological, and Gastrointestinal
Impairment. Front. Neurol. 10:944.
doi: 10.3389/fneur.2019.00944
A Novel TTC19 Mutation in a Patient
With Neurological, Psychological,
and Gastrointestinal Impairment
Parham Habibzadeh 1,2, Soroor Inaloo 3, Mohammad Silawi 1, Hassan Dastsooz 1,4,
Mohammad Ali Farazi Fard 1, Forough Sadeghipour 1, Zahra Faghihi 1,
Mohaddeseh Rezaeian 1, Majid Yavarian 1, Johann Böhm 5 and Mohammad Ali Faghihi 1,6*
1 Persian BayanGene Research and Training Center, Shiraz University of Medical Sciences, Shiraz, Iran, 2 Student Research
Committee, Shiraz University of Medical Sciences, Shiraz, Iran, 3Neonatal Research Center, Shiraz University of Medical
Sciences, Shiraz, Iran, 4 Italian Institute for Genomic Medicine (IIGM), University of Turin, Turin, Italy, 5 Institut de Génétique et
de Biologie Moléculaire et Cellulaire (IGBMC), Inserm, CNRS, Université de Strasbourg, Illkirch, France, 6Center for
Therapeutic Innovation, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine,
Miami, FL, United States
Mitochondrial complex III deficiency nuclear type 2 is an autosomal-recessive disorder
caused by mutations in TTC19 gene. TTC19 is involved in the preservation of
mitochondrial complex III, which is responsible for transfer of electrons from reduced
coenzyme Q to cytochrome C and thus, contributes to the formation of electrochemical
potential and subsequent ATP generation. Mutations in TTC19 have been found to
be associated with a wide range of neurological and psychological manifestations.
Herein, we report on a 15-year-old boy born from first-degree cousin parents, who
initially presented with psychiatric symptoms. He subsequently developed progressive
ataxia, spastic paraparesis with involvement of caudate bodies and lentiform nuclei with
cerebellar atrophy. Eventually, the patient developed gastrointestinal involvement. Using
whole-exome sequencing (WES), we identified a novel homozygous frameshift mutation
in the TTC19 gene in the patient (NM_017775.3, c.581delG: p.Arg194Asnfs∗16).
Advanced genetic sequencing technologies developed in recent years have not only
facilitated identification of novel disease genes, but also allowed revelations about novel
phenotypes associated with mutations in the genes already linked with other clinical
features. Our findings expanded the clinical features of TTC19 mutation to potentially
include gastrointestinal involvement. Further functional studies are needed to elucidate
the underlying pathophysiological mechanisms.
Keywords: mitochondrial diseases, mitochondrial encephalomyopathies, TTC19, mitochondrial complex III
deficiency, neurodegenerative diseases
BACKGROUND
Mitochondrial respiratory chain (MRC), consisting of five enzymatic complexes embedded in the
inner mitochondrial membrane, has an important role in providing cells with ATP. Mutations
in the nuclear or mitochondrial DNA affecting MRC could result in a wide array of disorders
with various neurological and non-neurological presentations (1). Complex III, consisting of 11
subunits, is responsible for the transfer of electrons from reduced coenzymeQ to cytochrome C and
thus, contributes to the formation of electrochemical potential ultimately leading to the production
of ATP (2).
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Mitochondrial complex III deficiency, nuclear type 2 (OMIM:
615157) is an autosomal-recessive disorder caused by mutations
in TTC19 gene. TTC19 (Entrez Gene: 54902; OMIM: 613814)
is involved in the preservation of complex III function by
allowing turnover of Rieske protein through removal of the N-
terminal proteolytic fragment of the protein (3). Mutations in
TTC19 have been shown to be linked with rapidly progressive
neurological impairment (2), spinocerebellar ataxia (4–6),
progressive psychosis (4), Leigh syndrome (7), developmental
delay and regression in childhood (2, 8–10), bilateral cherry red
spots, and failure to thrive (10). Clinical, neuroimaging, and
biochemical findings in patients with pathogenic mutations in
TTC19 gene are summarized in Table 1.
Herein, we report on a 15-year-old boy presenting with
psychiatric symptoms, progressive ataxia, spastic paraparesis,
bilious vomiting, and constipation with a novel homozygous
frameshift mutation in TTC19.
CASE PRESENTATION
The patient is a 15-year-old boy, who is the first and only
child of consanguineous healthy parents who were first cousins.
He initially presented at the age of 7 years with psychiatric
symptoms including aggressive behavior and hyperactivity for
which he was under treatment with methylphenidate (Ritalin),
risperidone, olanzapine, and biperiden. The patient had normal
psychomotor development until the age of 13 years, when
he began to develop speech difficulty. Between the age of 13
and 14, he started to experience gait disturbance and difficulty
walking, which progressed in the following year and made the
patient wheelchair-bound. On physical examination, the patient
was emaciated and cachectic; weighing 45 kg with a height of
165 cm, his body mass index (BMI) was 16.5 kg/m2. Neurological
examination was significant for bilateral hyperactive deep
tendon reflexes, severe ataxia, tremor, horizontal nystagmus,
and spasticity, which was more pronounced in the lower
extremities. The patient made limited eye contact and appeared
to have intellectual impairment. In addition, musculoskeletal
examination was notable for pes cavus.
Laboratory results including serum electrolytes, plasma
ammonia, liver function test, blood amino-acid analysis, and
cerebrospinal fluid examination were all normal. However, his
blood lactate level was elevated to 27 mg/dL (reference range:
4.5–19.8mg/dL). Magnetic resonance imaging (MRI) of the brain
showed hypersignal changes bilaterally in caudate bodies and
lentiform nuclei on T2 and fluid attenuated inversion recovery
imaging (FLAIR). The lesions appeared as hypodensities in
computed tomography (CT). In addition, cerebellar atrophy was
detected (Figure 1).
The patient’s condition deteriorated significantly in
subsequent months, leading to severe cognitive impairment
and mutism. In addition, the patient developed dysphagia,
bilious vomiting, and constipation. Upper endoscopy revealed
erythematous lesions distributed in the entire esophagus.
Furthermore, gastric mucosa in the fundus, body, and antrum
was hyperemic with multiple erosions. These lesions were
also seen in the bulb and the second part of duodenum. A
percutaneous endoscopic gastrostomy (PEG) tube was inserted
due to feeding problems.
Total genomic DNA was extracted from the patient’s blood
sample using QIAamp DNA Blood Mini kit (Qiagen, Germany).
Subsequently, whole-exome sequencing (WES) was performed
using Illumina NextSeq500 instrument. Variants with an allele
frequency of more than 0.005 in gnomAD, EXAC, and our
in-house database were excluded. In addition, synonymous and
non-coding variants were filtered. Subsequently, considering
the autosomal-recessive pattern of inheritance, homozygous,
and compound heterozygous variants were analyzed (Table S1).
Finally, correlation of the patient’s clinical findings with
phenotypes associated with the genes harboring identified
genetic variations revealed that our patient was homozygous
for a previously undescribed frameshift deletion mutation in
TTC19 gene (NM_017775.3: c.581delG: p.Arg194Asnfs∗16).
This novel mutation along with other previously reported
pathogenic variants are represented in Figure 2. Sanger
sequencing of exon six of the gene was also performed in
the patient and his parents, using the following forward
(5′-ATTCACAGTTGGCTCATCACTC-3′) and reverse (5′-
AGATGTTGTGTGCCCCACTA-3′) primers. It was confirmed
that both parents were heterozygous for the mutation, and that
the proband was homozygous for this mutation (Figure 3).
Written informed consent was obtained from the patient’s
parents. This study was conducted in accordance with ethical
standards of the declaration of Helsinki.
DISCUSSION AND CONCLUSION
Mitochondrial disorders are clinically and genetically
heterogeneous, greatly hindering the diagnosis of these
disorders. Recent advances made in genetic technologies,
allowing sequencing and in-depth investigation of the genome,
has substantially improved the diagnosis of mitochondrial
diseases. Autosomal-recessive cerebellar ataxias (ARCA) are a
diverse group of neurodegenerative disorders characterized by
movement incoordination and unsteadiness (12). A growing
number of defects in biological pathways such as deficiency
of DNA repair, defects in lipoprotein assembly, chaperone
dysfunction, and mitochondrial defects can lead to ARCA (12).
However, in almost half of the patients the genetic cause remains
elusive (13). Herein, we reported a mitochondrial ARCA in
a 15-year-old patient who presented with progressive ataxia,
spastic paraparesis, psychiatric, and gastrointestinal symptoms
with a novel frameshift deletion in TTC19 gene. Protein-protein
interaction analysis revealed an interaction of TTC19 with many
genes, including ZFYVE26, which has been identified as the
cause of autosomal-recessive spastic paraplegia 15 (14, 15).
Furthermore, animal models have highlighted the importance
of TTC19 gene. TTC19-null adult Drosophilia melanogaster
exhibited reduced lifespan, low fertility, adult-onset motor
impairment, and abnormal optomotor function (2).
The neurological and psychiatric manifestations of the patient
described here coincides well with the manifestations reported


































































Sex F M F M M M M F M F F M F M M M F M M
Age at onset 5 years 10 years 5 years 43 years 27 years 12 years 15 years 34 years 1 year 31 years 18 months 25 years 8 years Neonatal 19 months 3 years 6 years 3.5 years 7 years






































































NA + NA NA + + + + NA + + + + + NA NA NA + +
Behavioral
disorder
NA NA NA NA + + + + NA NA + + + NA NA NA – NA +
Ataxia + + + + + + + + NA + + + + + + + – + +
Dysphagia + + NA NA + + + + NA NA NA NA + + + + – + +
Dysarthria + + + + + + + + NA + + + – + + + – + +
Spasticity NA NA NA + + + + NA NA NA NA + – + + + – NA +













NA Olivo-ponto-cerebellar atrophy and
hypersignal changes in caudate,
putamen, cerebellar dentate nucleus,
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FIGURE 1 | Brain MRI. (A) Axial FLAIR image of the patient showing hyper-signal changes bilaterally in caudate bodies and lentiform nuclei. (B) Coronal T2 image
showing cerebellar atrophy.
FIGURE 2 | Schematic representation of TTC19 gene (GenBank accession no. NM_017775.3). The blue boxes indicate exons. Novel (shown in red) and previously
reported mutations are shown.
FIGURE 3 | Sequence chromatograms of (A,B) parents and (C) the patient. The arrow indicates the site of the causative mutation.
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earlier; progressive signs and symptoms of basal ganglia and
cerebellar dysfunction such as ataxia, dysarthria, and spasticity
were observed. Furthermore, psychiatric manifestations are
often seen in dominant types of cerebellar ataxia, such as
spinocerebellar ataxia 7 and 8; they are generally uncommon in
those with ARCA (16, 17). However, it seems that patients with
mutations in TTC19 gene are more likely to present psychiatric
manifestations, as described in our patient (4, 6).
Patients with mitochondrial disorders are frequently reported
to have gastrointestinal symptoms. These symptoms might be
the predominant presentation in disorders like mitochondrial
neurogastrointestinal encephalomyopathy (MNGIE), whereas in
other disorders like Leigh syndrome, gastrointestinal symptoms
are usually less prominent compared with neurological
presentations (18). Despite the fact that dysphagia is reported
in previous reports, constipation and bilious vomiting have not
hitherto been reported in the literature. This might be due to
intestinal pseudo-obstruction, which has also been reported in
other mitochondrial disorders (19, 20).
Advanced genetic sequencing technologies developed in
recent years, such as WES, have not only facilitated identification
of novel disease genes, but also allowed revelations about
novel phenotypes associated with mutations in the genes
already linked with other clinical features. Our findings
expanded the clinical features of TTC19 mutation to potentially
include gastrointestinal involvement. Further functional studies
are however needed to shed light over the underlying
pathophysiological mechanisms.
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